The US FDA New Drug Approvals in September 2024

Shots: PharmaShots has compiled a list of US FDA-approved drugs in the month of September 2024 The US FDA has approved a total of 7 new drugs including 4 new molecular entities and 3 biologics leading to the treatment of patients and advances in the healthcare industry The major highlighted drugs were Roche’s Tecentriq Hybreza & Ocrevus Zunovo for…

ByDipanshu DixitOctober 22, 2024

Onchilles Pharma at AACR 2024: Lev Becker in a Stimulating Conversation with PharmaShots

Shots: Recently, Onchilles Pharma unveiled findings from the late-stage preclinical data of its two candidates: N17350 and N17465 Today at PharmaShots, we had an engaging dialogue exchange with Lev Becker, Associate Professor, University of Chicago and Cofounder, Onchilles Pharma Lev highlights the unique novel mechanism that Onchilles Pharma leverages to treat a wide range of…

BySaurabh ChaubeyJune 19, 2024

The Beginner’s Guide to Medical Tourism

The popularity of medical tourism is overgrowing, with the global market projected to reach $31.91 billion by 2023. The industry is expected to experience a 14% cumulative annual growth rate (CAGR) from 2023-2027. Each year, over 10 million patients from different parts of the world seek assistance from doctors overseas. Medical tourism can provide access…

ByNatalia VolvakAugust 30, 2023

The US FDA New Drug Approvals in September 2024

Onchilles Pharma at AACR 2024: Lev Becker in a Stimulating Conversation with PharmaShots

The Beginner’s Guide to Medical Tourism

Contact US

FOLLW US

The US FDA New Drug Approvals in September 2024

Onchilles Pharma at AACR 2024: Lev Becker in a Stimulating Conversation with PharmaShots

The Beginner’s Guide to Medical Tourism

FOLLW US

Sign Up to Our Newsletter